Mankind Pharma Vice Chairman Juneja says BSV acquisition to aid future growth of Company
Advertisement
Mumbai: Rajeev Juneja, Vice Chairman and Managing Director of Mankind Pharma, has underscored the strategic significance of the company's recent acquisition of Bharat Serums and Vaccines (BSV). Juneja stated that the acquisition is poised to significantly enhance the company's value and support its future growth trajectory.
Mankind had announced that it will fully acquire Bharat Serums and Vaccines (BSV) from Advent International for an enterprise value of around Rs 13,630 crore on July 25.
Read also: Mankind Pharma to acquire 100 percent stake in Bharat Serums and Vaccines for Rs 13,630 crore
"One thing should be very clear, this acquisition is not to really add some kind of revenue, but to add a lot of value, future growth, entry barrier, super specialty business in Mankind," Juneja said in an analyst call.
Whatever the company is paying for BSV, it is very relevant as the company has "so much of value" with well established business, he said.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.